文献速递主动脉疾病

既往血管内主动脉瘤修复失败后应用开窗或分支支架再干预的系统综述

Systematic review of reintervention with fenestrated or branched devices after failed previous endovascular aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2022-11-12

本系统综述检索截至2022年6月15日的文献,纳入10项观察性研究、共423例既往EVAR失败后接受开窗/分支型EVAR(F/BEVAR)的患者。技术成功率为94.9%(319/336),30天死亡率为2.4%(10/423),随访期间死亡率为14.8%(47例),再干预率为16.5%(50/303)。作者认为围术期技术成功率高、死亡率低,但需要更多数据以得出可靠结论。

要点

  • 既往EVAR失败后F/BEVAR的技术成功率为94.9%(319/336例干预)。
  • 30天死亡率为2.4%(10/423),脊髓缺血发生率为2.4%(7例)。
  • 平均随访18个月(范围1-77个月),随访期间再干预率为16.5%(50/303)。

核心结论

  • 根据现有文献,既往EVAR失败后行F/BEVAR可获得高技术成功率和低围术期死亡率。
  • 中期死亡率和再干预率可接受。
  • 然而,需要进一步数据才能就F/BEVAR在既往EVAR失败后的安全性和耐久性得出可靠结论。

研究设计与样本

  • 系统综述遵循PRISMA声明并在PROSPERO预注册(注册号CRD42022350436)。
  • 检索Ovid平台的MEDLINE、EMBASE和CENTRAL数据库截至2022年6月15日的英文文献。
  • 纳入2000-2022年的观察性研究和病例系列,要求至少5例既往EVAR失败后接受F/BEVAR的患者,且报告技术成功、30天死亡率及随访期死亡率和再干预率。
  • 采用纽卡斯尔-渥太华量表评估偏倚风险。
  • 初检获得2558篇报告,最终纳入10项研究(其中2项为前瞻性),共423例患者。

主要发现

  • 再干预指征为Ia型内漏者占44.9%。
  • 7项研究报告了技术成功,按各研究标准319/336例干预(94.9%)成功。
  • 423例患者中30天内死亡10例(2.4%)。
  • 7例出现脊髓缺血(2.4%),报告23例急性肾损伤事件(6.8%)。
  • 平均随访18个月(范围1-77个月),随访期间死亡47例(14.8%),303例手术中再干预50例(16.5%)。

局限性

  • 作者指出需要进一步数据才能就F/BEVAR在既往EVAR失败后的安全性和耐久性得出可靠结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A proximal seal extension, after previously failed standard endovascular abdominal aortic aneurysm repair (EVAR), has been described using various endovascular techniques. The aim of the present systematic review was to assess the technical success, 30-day mortality, and mortality and reintervention rates during the available follow-up for patients managed with endovascular methods after failed endovascular repair. METHODS: The present systematic review followed the PRISMA (preferred reporting items for systematic reviews and meta-analyses) statement and was preregistered at PROSPERO (no. CRD42022350436). A search of the English literature, via Ovid, using the MEDLINE, EMBASE, and CENTRAL databases, until June 15, 2022, was performed. Observational studies (2000-2022) and case series with at least five patients who had undergone fenestrated/branched EVAR (F/BEVAR) after failed EVAR were considered eligible. Technical success and mortality at 30 days and the mortality and reintervention rates during available follow-up had to have been reported. The Newcastle-Ottawa scale was used to assess the risk of bias. The primary outcome was technical success and mortality at 30 days. RESULTS: The initial search yielded 2558 reports. Ten studies were considered eligible, two of which were prospective. A total of 423 patients had undergone F/BEVAR after failed EVAR. The indication for reintervention was the presence of a type Ia endoleak in 44.9%. Technical success was reported in seven studies, and 319 of 336 interventions were considered successful (94.9%), according to each study's criteria. Of the 423 patients, 10 had died within 30 days (2.4%). Seven patients had presented with spinal cord ischemia (2.4%). Twenty-three acute kidney injury events were reported (6.8%). The mean follow-up was 18 months (range, 1-77 months). During follow-up, 47 deaths were reported (14.8%). Finally, 50 reinterventions of 303 procedures (16.5%) had been performed. CONCLUSIONS: According to the available literature, F/BEVAR after failed EVAR can be performed with high technical success and low mortality during the perioperative period. The midterm mortality and reintervention rates were acceptable. However, further data are needed to provide firm conclusions regarding the safety and durability of F/BEVAR after failed EVAR.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nana P, Kölbel T, Behrendt CA, et al. Systematic review of reintervention with fenestrated or branched devices after failed previous endovascular aortic aneurysm repair. J Vasc Surg. 2022. PMID: 36375726. doi:10.1016/j.jvs.2022.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。